5.08.2022 A multi-country study of monkeypox being launched – first cases enrolled in Geneva Ecraid is part of yet another promising initiative aimed at tackling the monkeypox outbreak.
31.07.2022 Thinking outside the box with Ana C. Hernandez Ana C. Hernandez moved to France five years ago to work at the Clinical Research Centre of Limoges. When we met, she was eager t…
7.07.2022 European response to monkeypox virus outbreak Ecraid is assessing its readiness to respond in the event the monkeypox outbreak spreads further in Europe.
8.06.2022 Ground-breaking tool helps limit antimicrobial resistance spread across borders An easy-to-use, freely accessible AMR Travel Tool developed by Ecraid's epidemiology network.
17.05.2022 New POS-Disease X publication: Team tackles acute hepatitis mystery An unusually high number of cases of unexplained acute hepatitis among young children has been puzzling health experts.
10.05.2022 Ecraid introduces new COO Nils Visser Utrecht, 10 May 2022 – The Ecraid Management Board is pleased to announce the appointment of Nils Visser as its new Chief Operat…
